QA: MERIDIAN BIOSCIENCE INC in us_medicinal_products/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000794172_2022_MERIDIAN_BIOSCIENCE_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.3221187688699367, 'aggregate_val': 449722000, 'exp_sum': 663423000, 'exp_to_value': {'AssetsCurrent': 192807000, 'AssetsNoncurrent': 213701000, 'PropertyPlantAndEquipmentNet': 43214000, 'Goodwill': 198819000, 'remainder_Assets': 14882000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.008614002857726066, 'aggregate_val': 121420000, 'exp_sum': 122475000, 'exp_to_value': {'LiabilitiesNoncurrent': 74263000, 'LiabilitiesCurrent': 48212000, 'remainder_Liabilities': 0}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000794172, MERIDIAN BIOSCIENCE INC

  xvar xval
0 LiabilitiesNoncurrent 74,263,000
1 LiabilitiesCurrent 48,212,000
2 remainder_Liabilities -1,055,000
3 AssetsCurrent 192,807,000
4 AssetsNoncurrent 213,701,000
5 PropertyPlantAndEquipmentNet 43,214,000
6 Goodwill 198,819,000
7 remainder_Assets -198,819,000
8 GeneralAndAdministrativeExpense 193,069,000
9 ResearchAndDevelopmentExpense 23,911,000
10 remainder_Expenses 26,926,000
11 remainder_Revenues 317,896,000
12 remainder_NetIncome -2,583,000
13 remainder_ComprehensiveNetIncome 2,058,000
  yvar yval
0 Liabilities 121,420,000
1 Assets 449,722,000
2 Expenses 243,906,000
3 Revenues 317,896,000
4 StockholdersEquity 328,302,000
5 NetIncome 71,407,000
6 ComprehensiveNetIncome 72,436,000
7 BaseVar 568,792,500
8 EconomicCapitalRatio 1.23

Edgar->Model Mapping

Feature Distribution

Change over Time